Skip to content
healthcare.dev

AZACITIDINE

NDC 55150-393, AZACITIDINE, injection, powder, lyophilized, for solution, from Eugia US LLC.

Product NDC
55150-393
Status
Listed
Labeler
Eugia US LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215066
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55150-393 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AZACITIDINE100 mg/4mL

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
55150-393-01551500393011 VIAL, SINGLE-DOSE in 1 CARTON (55150-393-01) / 4 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ecd108bd-bb5f-4b2e-ad91-210fca452e9b
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=55150-393

Use it

Look up 55150-393 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55150-393 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55150-393. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.